Catalyst Crew Technologies Corp. (OTC: CCTC), an artificial intelligence-driven healthcare technology company, today announced the development and planned commercialization of its artificial intelligence-enabled healthcare analytics platform (the “AI Healthcare Platform”). The platform is designed to assist healthcare providers and medical organizations in analyzing patient data, identifying potential clinical risks, and supporting more informed medical decision-making through AI-driven analytics.
The AI Healthcare Platform integrates multiple data inputs, including medical records, diagnostic data, and patient-reported information, to generate insights intended to assist healthcare professionals in evaluating patient conditions and coordinating care. The Company believes that AI-enabled healthcare analytics technologies may play an increasingly important role in improving efficiency across healthcare systems, particularly in emerging markets where access to specialized medical resources can be limited.
The platform forms part of the Company’s broader digital health ecosystem, which also includes a technology-enabled healthcare services coordination platform for telehealth infrastructure, remote patient monitoring, and hybrid home-based medical services. Management intends to integrate the AI Healthcare Platform across its existing and planned healthcare infrastructure initiatives, serving as a core technology layer supporting data analysis, care coordination tools, and clinical decision-support capabilities. As Catalyst Crew continues to develop its healthcare services platform and evaluate potential partnerships, the AI Healthcare Platform is expected to support scalable technology deployment across multiple healthcare delivery environments.
Catalyst Crew Technologies intends to prioritize market development in Latin America, where the Company believes AI-enabled healthcare technologies may help expand access to medical expertise, support remote patient monitoring, and improve healthcare system efficiency. The region represents a significant opportunity for digital health innovation as healthcare systems increasingly seek scalable technology solutions to improve diagnostic capabilities and support remote patient care.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated, “Artificial intelligence has the potential to transform how healthcare providers analyze clinical information and coordinate patient care. Our goal is to develop scalable technology platforms that can assist medical professionals in improving efficiency, expanding access to care, and supporting better healthcare outcomes.”
The Company intends to continue developing and refining its healthcare technology platforms and evaluating opportunities for strategic partnerships, pilot deployments, and market expansion initiatives. For more information, visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
